Literature DB >> 519660

Estimation of circulatory parameters in patients with acute myocardial infarction. Significance for calculation of enzymatic infarct size.

G M Willems, A M Muijtjens, F H Lambi, W T Hermens.   

Abstract

Estimation of infarct size from enzyme activities in plasma or serum presupposes known values of circulatory parameters such as the extravascular distribution volume Ve and the permeability constant P for the transport of enzyme between intravascular volume Vi and Ve. In man, parameter values are used that are extrapolated either from values found in the dog or from turnover studies of non-myocardial proteins. Large systematic errors can be introduced in this way, as demonstrated in this study. It is shown that by simultaneous determination of two different enzymes in the same patient, estimates of circulatory parameters are obtained. The method is applied to creatine kinase (CK) and alpha-hydroxybutyrate dehydrogenase (HBDH) plasma activities in 36 patients with acute myocardial infarction (AMI). The following results are obtained: 1. Exchange of enzyme between Vi and Ve is much slower and clearance of CK is much faster than presently assumed in the literature. 2. Release of CK and HBDH into the circulation is proportional to the amounts of these enzymes present in the myocardium. This finding is supported by data on early enzyme release. 3. Quantitation of HBDH release needs a two-compartment model, while for CK a one-compartment model can be used in good approximation. 4. Release of CK and HBDH after AMI continues up to 96 hours. 5. Using obtained parameter values, a simulated model demonstrates that estimation of clearance rates of CK from exponential fits on plasma levels results in large errors. This may explain recent conflicting results in validation of enzymatic estimates of infarct size.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519660     DOI: 10.1093/cvr/13.10.578

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction.

Authors:  C de Zwaan; G M Willems; F Vermeer; J Res; F W Verheugt; A van der Laarse; M L Simoons; J Lubsen; W T Hermens
Journal:  Br Heart J       Date:  1988-02

2.  Extent of myocardial damage after open-heart surgery assessed from serial plasma enzyme levels in either of two periods (1975 and 1980).

Authors:  H A Davids; W T Hermens; L Hollaar; A van der Laarse; H A Huysmans
Journal:  Br Heart J       Date:  1982-02

Review 3.  Creatine kinase: race-gender differences in patients hospitalized for suspected myocardial infarction.

Authors:  J C Cook; E Wong; L J Haywood
Journal:  J Natl Med Assoc       Date:  1990-04       Impact factor: 1.798

4.  A new quantitative method for the analysis of cardiac perfusion tomography (SPET): validation in post-infarct patients treated with thrombolytic therapy.

Authors:  L Mortelmans; J Nuyts; I Scheys; F Wackers; E Lesaffre; T Brzostek; M De Roo; H De Geest; P Suetens; A Verbruggen
Journal:  Eur J Nucl Med       Date:  1993-12

5.  Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

Authors:  F Van de Werf; A E Arnold
Journal:  BMJ       Date:  1988-11-26

6.  Infarct size estimation from serial CK MB determinations: peak activity and predictability.

Authors:  J W Fiolet; H F ter Welle; F J van Capelle; K I Lie
Journal:  Br Heart J       Date:  1983-04

7.  Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans.

Authors:  J F Glatz; A H Kleine; F A van Nieuwenhoven; W T Hermens; M P van Dieijen-Visser; G J van der Vusse
Journal:  Br Heart J       Date:  1994-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.